Cargando…
Preexisting comorbidities shape the immune response associated with severe COVID-19
BACKGROUND: Comorbidities are risk factors for development of severe coronavirus disease 2019 (COVID-19). However, the extent to which an underlying comorbidity influences the immune response to severe acute respiratory syndrome coronavirus 2 remains unknown. OBJECTIVE: Our aim was to investigate th...
Autores principales: | Kreutmair, Stefanie, Kauffmann, Manuel, Unger, Susanne, Ingelfinger, Florian, Núñez, Nicolás Gonzalo, Alberti, Chiara, De Feo, Donatella, Krishnarajah, Sinduya, Friebel, Ekaterina, Ulutekin, Can, Babaei, Sepideh, Gaborit, Benjamin, Lutz, Mirjam, Jurado, Nicole Puertas, Malek, Nisar P., Göpel, Siri, Rosenberger, Peter, Häberle, Helene A., Ayoub, Ikram, Al-Hajj, Sally, Claassen, Manfred, Liblau, Roland, Martin-Blondel, Guillaume, Bitzer, Michael, Roquilly, Antoine, Becher, Burkhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212690/ https://www.ncbi.nlm.nih.gov/pubmed/35716951 http://dx.doi.org/10.1016/j.jaci.2022.05.019 |
Ejemplares similares
-
Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia
por: Kreutmair, Stefanie, et al.
Publicado: (2022) -
Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia
por: Kreutmair, Stefanie, et al.
Publicado: (2021) -
T(H) Cells and Cytokines in Encephalitogenic Disorders
por: Krishnarajah, Sinduya, et al.
Publicado: (2022) -
Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature
por: Ingelfinger, Florian, et al.
Publicado: (2021) -
S257: CAR T CELLS AND THEIR IMMUNE ENVIRONMENT SHAPE DISTINCT IMMUNE PROFILES IN RESPONSE AND TOXICITY IN B CELL LYMPHOMA PATIENTS
por: Kreutmair, Stefanie, et al.
Publicado: (2023)